Enhancing Health Outcomes with Geriatric-Specific Cancer Rehabilitation

By Melike Belenli Gümüş

September 19, 2024

Introduction

With the ageing population, the incidence of cancer among older adults is set to surge significantly. By 2040, it is projected that more than 70% of all cancer cases will be diagnosed in individuals aged 65 and above. Older cancer patients often face intricate health challenges due to various factors such as comorbid chronic conditions, functional limitations, malnutrition, cognitive decline, and geriatric syndromes. These complexities can impede their ability to withstand and recover from cancer treatments. Compared to younger patients, older individuals undergoing cancer treatment often experience high level of toxicity, prolonged hospital stays, treatment delays, incomplete therapy, and diminished quality of life (QoL). Studies show that up to half of older cancer survivors report enduring physical disabilities and reduced health status even a decade post-diagnosis. Therefore, tailored geriatric-specific cancer rehabilitation programmes are necessary to enhance the QoL for older adults undergoing cancer treatment.

Evaluating Geriatric-Specific Cancer Rehabilitation Programs

A recent study conducted in Al-Ahsa, Saudi Arabia, examined the efficacy of a tailored geriatric cancer rehabilitation programme on the QoL of 130 cancer patients aged 65 to over 80, with a slight concentration in the 70-74 age group. The most common cancer types among participants were breast, prostate, lung, and colorectal cancers.

The research revealed that participants in the rehabilitation group exhibited significantly higher QoL scores across physical, social, and functional domains compared to those receiving standard oncology care. Participants in the rehabilitation group experienced reduced symptom burden and functional deficits. They also showed better emotional health and social connectedness. These benefits enabled seniors to maintain independence, tolerate necessary treatments, and achieve some control over their healing journey.

Figure 1. Quality of Life Scores.

Comprehensive Geriatric Assessment: A Key to Personalised Care

Comprehensive geriatric assessment (CGA) plays a vital role in delivering patient-centred care by offering detailed insights into the medical, psychosocial, and functional capacities of older cancer patients. Through CGA, healthcare providers can tailor care plans that optimise cancer outcomes while addressing the individual health needs and goals of each patient. By evaluating factors like comorbidities, fall risk, medications, cognitive function, and nutritional status, CGA enables personalised care that enhances diagnostic accuracy, treatment tolerance, survival rates, and overall QoL for vulnerable older cancer patients.

Specialised Geriatric Cancer Rehabilitation: A Promising Approach

Geriatric-specific cancer rehabilitation interventions hold promise in addressing the complex needs of older cancer patients and improving their health outcomes. These programmes encompass a range of interventions, including physical and occupational therapy, nutritional counselling, pain management, and psychological support, aimed at enhancing patients’ physical, social, and psychological well-being. Evidence suggests that participation in multidisciplinary cancer rehabilitation programmes leads to significant improvements in physical and emotional symptoms, treatment tolerance, functional independence, and overall QoL for cancer patients across different age groups. However, persistent health system barriers limit referral and access to these programs. Addressing these barriers is crucial as cancer incidence among older adults continues to rise.

Conclusion

Geriatric-specific cancer rehabilitation offers meaningful improvements in QoL for older adults. The study highlighted the necessity for collaborative efforts between oncology and geriatrics to address the unique needs of this population. By focusing on personalised care, comprehensive assessments, and tailored rehabilitation interventions, healthcare providers can empower older cancer patients to navigate their cancer journey with resilience and improved well-being. As the population ages and cancer rates rise, it is imperative to invest in evidence-based interventions like geriatric cancer rehabilitation to ensure that older adults receive the care and support they need to enhance their QoL and overall health.

Reference url

Recent Posts

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.